A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML) (Q73586771)
Jump to navigation
Jump to search
scientific article published on 01 July 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML) |
scientific article published on 01 July 1997 |
Statements
A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML) (English)
A Leahey
K Kelly
L B Rorke